Research News and Highlights

Explore news, updates and cutting-edge research related to real-world data and ALZ-NET.

Network news

Radiology Takes on Alzheimer's Disease

Anticipating increasing numbers of Alzheimer’s disease and related dementia patients, radiologists, and other medical professionals are leveraging innovative tools and collaborative platforms to enhance diagnosis and treatment management. ALZ-NET consolidates recommended protocols for PET, MRI, and related modalities, offering essential resources on training, scanner specifications, sequences, and reporting standards. Additionally, ALZ-NET is a hub for patients to stay updated on Alzheimer’s news, engage with the community, navigate Medicare billing, and connect with dementia specialists.

Date published: October 4, 2023
Publication: American College of Radiology

Experts reframe ‘clinical meaningfulness’ in Alzheimer’s

The Alzheimer’s Association convened a workgroup of experts in 2022 to discuss and reframe what clinical meaningfulness means in the context of Alzheimer’s disease. This news article and the accompanying published manuscript highlight that slowing disease progression has meaningful benefits for patients and families, especially in early Alzheimer’s. They also discuss considerations of benefits from the past 18 months as seen in clinical trials and the likely need for combination therapies.

Date published: February 7, 2023
Publication: Medical Xpress

Alzheimer’s Association Launches ALZ-NET: A Long-Term Data Collection and Sharing Network for New Treatments

The Alzheimer’s Association announces that the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) – a new platform that will collect long-term clinical and safety data from patients treated with FDA-approved Alzheimer’s disease therapies in real-world clinical settings – is launched and live.

Date published: August 1, 2022
Publication: Alzheimer’s Association

More ALZ-NET news and highlights

Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease (AD), January 31, 2024

Isaac Health joins ALZ-NET as a participating telehealth site, September 6, 2023

FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval (lecanemab), July 6, 2023

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease (brexpiprazole), May 11, 2023

Emerging Therapies for Early Alzheimer’s Disease, April 3, 2023

FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment (lecanemab), January 6, 2023

Alzheimer’s Association Launches ALZ-NET Registry for Study of New Treatments for Alzheimer's Disease in Real-World Setting, August 2, 2022

Working Towards a World Without Alzheimer’s and All Other Dementia, November 26, 2021

Alzheimer’s Association announces national data registry for quick, transparent data sharing, November 12, 2021

National Alzheimer Disease Registry Announced to Collect Clinical Practice Data, November 12, 2021

Publications from ALZ-NET

ALZ-NET: Using Real World Evidence to Inform the Future of Alzheimer’s Treatment and Care
Published: December 2022

Alzheimer’s Association launches ALZ-NET: A long-term data collection and sharing network for new treatment
Published: September 2022